Terms: = Lung cancer AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712 AND Treatment
27 results:
1. Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor
Kaneko K; Nagao M; Ueda K; Yamamoto A; Sakai S
Ann Nucl Med; 2024 Apr; 38(4):278-287. PubMed ID: 38386272
[TBL] [Abstract] [Full Text] [Related]
2. Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing.
Nagasaka M; Zhang SS; Baca Y; Xiu J; Nieva J; Vanderwalde A; Swensen JJ; Spetzler D; Korn WM; Raez LE; Liu SV; Ou SI
BMC Cancer; 2023 Oct; 23(1):1000. PubMed ID: 37853341
[TBL] [Abstract] [Full Text] [Related]
3. Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas.
Goldschmid H; Kluck K; Ball M; Kirchner M; Allgäuer M; Winter H; Herth F; Heußel CP; Pullamsetti SS; Savai R; Yong TTK; Schirmacher P; Peters S; Thomas M; Christopoulos P; Budczies J; Stenzinger A; Kazdal D
Lung Cancer; 2023 Jun; 180():107212. PubMed ID: 37141769
[TBL] [Abstract] [Full Text] [Related]
4. [Efficacy and Safety of Radiotherapy Combined with Immunotherapy
for Brain Metastases from lung cancer: A Meta-analysis].
Xu L; Chen Y; Wang M
Zhongguo Fei Ai Za Zhi; 2022 Oct; 25(10):715-722. PubMed ID: 36285391
[TBL] [Abstract] [Full Text] [Related]
5. DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment.
Bernhardt D; König L; Grosu AL; Rieken S; Krieg SM; Wick W; Wiestler B; Schmidt-Graf F; Sahm F; Gempt J; Meyer B; Krause BJ; Petersen C; Fietkau R; Thomas M; Giordano F; Wittig-Sauerwein A; Debus J; Tabatabai G; Hau P; Steinbach J; Combs SE;
Strahlenther Onkol; 2022 Nov; 198(11):971-980. PubMed ID: 36038670
[TBL] [Abstract] [Full Text] [Related]
6. DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis.
Bernhardt D; König L; Grosu A; Wiestler B; Rieken S; Wick W; Gempt J; Krieg SM; Schmidt-Graf F; Sahm F; Meyer B; Krause BJ; Petersen C; Fietkau R; Thomas M; Giordano F; Wittig-Sauerwein A; Debus J; Tabatabai G; Hau P; Steinbach J; Combs SE;
Strahlenther Onkol; 2022 Oct; 198(10):873-883. PubMed ID: 36038669
[TBL] [Abstract] [Full Text] [Related]
7. u2af1 mutation connects DNA damage to the alternative splicing of RAD51 in lung adenocarcinomas.
Chen C; Zhou P; Zhang Z; Liu Y
Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):740-747. PubMed ID: 35434831
[TBL] [Abstract] [Full Text] [Related]
8. From Postoperative to Preoperative: A Case Series of Hypofractionated and Single-Fraction Neoadjuvant Stereotactic Radiosurgery for Brain Metastases.
Udovicich C; Ng SP; Tange D; Bailey N; Haghighi N
Oper Neurosurg (Hagerstown); 2022 Apr; 22(4):208-214. PubMed ID: 35234410
[TBL] [Abstract] [Full Text] [Related]
9. Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors.
Moore A; Yust-Katz S; Icht O; Eliyahou R; Gordon N; Cohen AY; Goldstein IM; Peled N; Seigal T; Amiel A; Dudnik E
J Neurol Sci; 2021 Aug; 427():117556. PubMed ID: 34186494
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
11. Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases.
Kowalski ES; Remick JS; Sun K; Alexander GS; Khairnar R; Morse E; Cherng HR; Berg LJ; Poirier Y; Lamichhane N; Becker S; Chen S; Molitoris JK; Kwok Y; Regine WF; Mishra MV
Radiat Oncol; 2020 Oct; 15(1):245. PubMed ID: 33109224
[TBL] [Abstract] [Full Text] [Related]
12. Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with
Ortiz-Cuaran S; Mezquita L; Swalduz A; Aldea M; Mazieres J; Leonce C; Jovelet C; Pradines A; Avrillon V; Chumbi Flores WR; Lacroix L; Loriot Y; Westeel V; Ngo-Camus M; Tissot C; Raynaud C; Gervais R; Brain E; Monnet I; Giroux Leprieur E; Caramella C; Mahier-Aït Oukhatar C; Hoog-Labouret N; de Kievit F; Howarth K; Morris C; Green E; Friboulet L; Chabaud S; Guichou JF; Perol M; Besse B; Blay JY; Saintigny P; Planchard D
Clin Cancer Res; 2020 Dec; 26(23):6242-6253. PubMed ID: 32859654
[TBL] [Abstract] [Full Text] [Related]
13. PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice.
Eguren-Santamaria I; Sanmamed MF; Goldberg SB; Kluger HM; Idoate MA; Lu BY; Corral J; Schalper KA; Herbst RS; Gil-Bazo I
Clin Cancer Res; 2020 Aug; 26(16):4186-4197. PubMed ID: 32354698
[TBL] [Abstract] [Full Text] [Related]
14. Optimal Target Delineation and treatment Techniques in the Era of Conformal Photon and Proton Breast and Regional Nodal Irradiation.
Kowalski ES; Feigenberg SJ; Cohen J; Fellows Z; Vadnais P; Rice S; Mishra MV; Molitoris JK; Nichols EM; Snider JW
Pract Radiat Oncol; 2020; 10(3):174-182. PubMed ID: 31786234
[TBL] [Abstract] [Full Text] [Related]
15. Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From lung cancer: A Retrospective Review.
Sharma A; Mountjoy LJ; Butterfield RJ; Zhang N; Ross HJ; Schild SE; Sio TT; Daniels TB; Paripati HR; Mrugala MM; Vora SA; Patel NP; Zimmerman RS; Ashman JB; Porter AB
Am J Clin Oncol; 2020 Feb; 43(2):128-132. PubMed ID: 31764021
[TBL] [Abstract] [Full Text] [Related]
16. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
Donovan EK; Parpia S; Greenspoon JN
Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
[TBL] [Abstract] [Full Text] [Related]
17. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S
Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084
[TBL] [Abstract] [Full Text] [Related]
18. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract] [Full Text] [Related]
19. Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis.
Narloch JL; Farber SH; Sammons S; McSherry F; Herndon JE; Hoang JK; Yin FF; Sampson JH; Fecci PE; Blackwell KL; Kirkpatrick JP; Kim GJ
Neuro Oncol; 2017 Oct; 19(10):1391-1397. PubMed ID: 28472527
[TBL] [Abstract] [Full Text] [Related]
20. Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
Miller JA; Bennett EE; Xiao R; Kotecha R; Chao ST; Vogelbaum MA; Barnett GH; Angelov L; Murphy ES; Yu JS; Ahluwalia MS; Suh JH; Mohammadi AM
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1060-1069. PubMed ID: 27742540
[TBL] [Abstract] [Full Text] [Related]
[Next]
